LOINCActive

LOINC Code 62981-6: PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301

62981-6 is a LOINC code used to identify PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301 in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301. It is commonly used with the system or sample type ^Patient.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301. It is commonly used with the system or sample type ^Patient.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Method: PhenX

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301
  • The communication subscale of the Ages & Stages Questionnaires®, Third Edition (ASQ-3) includes 6 questions that screen young children from 24-30 months for developmental delays in language skills. The ASQ-3- is completed by a parent (or child's caregiver) or by an examiner asking a parent (or child's caregiver) questions about the child. The protocol includes scoring instructions. Additionally, the Brookes Publishing Company offers an optional online management system for ASQ-3-called ASQ Online. In order for speech and language assessments to be considered valid, the investigator should make sure that the respondent speaks English well. The respondent should have hearing and cognitive ability adequate for understanding the items and evaluating the child's speech and language ability. For genetic studies, children should be assessed for hearing or nonverbal impairment as related factors that can contribute to low performance. Language impairment can appear without these factors but if these factors appear, the genetics of the language impairment may be confounded with the genetics of the related factors. The Ages & Stages Questionnaires®, Third Edition (ASQ-3) is a proprietary, fee-based instrument that is available for purchase from Brookes Publishing Company. The communication portion of the Ages & Stages Questionnaires®, Third Edition (ASQ-3(tm)) is not sold separately.
  • Child speech age stages proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301Child speech age stages protoPANEL.PHENX-Pt^PatientPhenX

Frequently asked questions

Code details

Code62981-6
SystemLOINC
Display namePhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301
Short nameChild speech age stages proto
ComponentPhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301
Property-
TimingPt
System (specimen)^Patient
Scale-
MethodPhenX
ClassPANEL.PHENX
StatusACTIVE

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.36
Last changed2.81

Part names

PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301-Pt^PatientPhenXPoint in time (spot)

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.